Sample size estimation for cluster randomized controlled trials by Ribeiro, Daniel C
Ribeiro DC, Milosavljevic S, Abbott JH. Sample Size Estimation for Cluster Randomized Controlled Trials. 





Title: Sample size estimation for cluster randomized controlled trials 
 
Daniel Cury Ribeiro, PT, PhD – School of Physiotherapy, Centre for Health, Activity and 
Rehabilitation Research, University of Otago 
 
Stephan Milosavljevic, PT, PhD – School of Physical Therapy, College of Medicine, University of 
Saskatchewan 
 
J. Haxby Abbott, DPT, PhD, FNZCP – Department of Surgical Sciences, Dunedin School of 
Medicine, University of Otago 
 
Corresponding author: 
Daniel Cury Ribeiro 
325 Great King Street, Dunedin, New Zealand 
Centre for Health, Activity and Rehabilitation Research – School of Physiotherapy – University of 
Otago 
Email: Daniel.ribeiro@otago.ac.nz  
 
Reference: Ribeiro, D.C.; Milosavljevic, S.; Abbott, J.H. (2018). Sample size estimation for cluster 
randomized controlled trials. Musculoskeletal Science and Practice, 34, 102-111 
 
DOI: https://doi.org/10.1016/j.msksp.2017.10.002  
 
 
Ribeiro DC, Milosavljevic S, Abbott JH. Sample Size Estimation for Cluster Randomized Controlled Trials. 






Cluster randomized controlled trials (cRCTs) are commonly used by clinical researchers. The 
advantages of cRCTs include preventing treatment contamination, enhancing administrative 
efficiency, convenience, external validity, ethical considerations, and likelihood of increased 
compliance by participants. However, when designing a cRCT, clinical researchers are faced with 
challenges, such as cluster units that may not have an equal number of participants within each. 
In this Technical Note, we discuss approaches for estimating the sample size, while taking into 
account unequal cluster sizes, and strategies for optimizing the design of cluster trials.  
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Randomized controlled trials (RCTs) are the gold standard design for experimental studies, as 
they can reduce many of the risks of bias that threaten clinical trials.3,18 However, there remain 
other risks of bias that random allocation alone does not address.19 Treatment contamination is 
one example, and can occur when treatment providers or participants learn what the ‘other’ 
group have been doing, and begin to blend that into their allocated intervention, thus 
‘contaminating’ it. This corrupts the internal validity of the study, weakens its ability to detect 
between-groups differences, resulting in falsely concluding the trial treatment does not have a 
significant effect, when in truth it does (Type II error). When treatment contamination is a risk, a 
cluster RCT (cRCT) is recommended.3,6,18,19  
 
In cRCT, randomization is done at the level of the study sites, centres, clinics or clinicians.18 All 
participants attending that site or clinician are automatically in that “cluster”, and receive the 
intervention allocated to the cluster.3 This reduces the likelihood of contact with the clinicians or 
participants of the ‘other’ group. Other advantages of a cRCT include enhanced administrative 
efficiency, convenience, increased external validity, ethical considerations, and likelihood of 
increased compliance by participants.3,6,18 On the other hand, cRCT design reduces the statistical 
efficiency of the trial,7,8,17 adds complexity to the statistical approach for estimating the sample 
size and analysing the main findings.3,18 Obtaining a robust estimate of the required sample size 
is crucial for conducting a trial that is statistically sound and financially feasible.18,20  
 
This technical note aims to discuss factors that affect sample size estimation of a cRCT, and 
present different approaches to estimate the sample size when designing a two-arm, cRCT with a 
continuous outcome measure. Numerous factors need to be taken into account when designing 
and estimating the sample size of a cRCT (Table 1). Below, we present an overview of each of 
these factors, and the effect of these on planning and estimating sample size of a cRCT. 
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Table 1. Effect of different factors on the design and sample size of cluster randomized controlled 
trials. 
Factor Effect on required sample size 
Design effect Cluster RCTs add sampling error compared with standard RCTs, therefore 
are statistically less efficient and require a larger sample size 
Number of clusters The greater the number of clusters, the smaller the required sample size 




The smaller the ICC, the smaller the required sample size 
Allocation ratio Equal allocation ratio requires smaller sample size 
Attrition  Researchers may consider accounting for individual or cluster drop-outs 
Baseline 
measurements 
Including covariates into the analysis increases statistical power, reducing 
the required sample size 
Outcome measure The type of outcome measure (i.e., binary, continuous, count, ordinal, time-
to-event and rate) dictates the formula used to estimate the sample size of 
the trial.  
 
The design effect 
Cluster RCTs are statistically less efficient than normal RCTs, due to the problem of variance 
inflation, caused by the fact that participants within a cluster unit are dependent, which increases 
sampling error in this type of trial.4,20 To account for the statistical inefficiency of cRCTs, a larger 
sample size is usually required, when compared to a standard RCT. 
 
There are different methods for estimating sample size of cRCT.3,20 A common and simple 
approach to estimate sample size for a cluster trial is to multiply the estimated sample size of a 
standard RCT by a factor, referred to as the “design effect” (DE) (Equation 1). Inflating the sample 
size of a standard trial by DE increases the statistical power of the cRCT.5  
 
Equation 1 
𝐷𝐸 = 1 + (𝑛 − 1) × 𝜌     (1) 
Where: 
DE = design effect; 
n = cluster size (i.e. number of participants per cluster); 
= intracluster correlation coefficient; 
 
 
The DE is a function of cluster size and the intracluster correlation coefficient (ICC). The ICC 
measures the degree of similarity of clustered data,18 and takes into account how much the 
variance differs within and between-clusters.10  Therefore, the larger the ICC or the cluster size, 
the larger the DE. The impact of cluster size and ICC on the DE is illustrated in Figure 1.  
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Figure 1. Relationship between intracluster correlation coefficient (x axis), the Design Effect (y 
axis) and the cluster size.  
Black line with square = cluster size of 2 participants per cluster; Grey dashed line = cluster size of 20 
participants per cluster; Grey line with circle = cluster size of 50 participants per cluster; Dotted black line 




The total number of participants (considering a two-arm trial, with equal allocation) for a cRCT 
is defined by Equation (2): 
 
Equation 2 
𝑆𝑆𝑐𝑙𝑢𝑠𝑡𝑒𝑟 𝑅𝐶𝑇 =  𝑆𝑆𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑅𝐶𝑇 ×  DE   (2) 
Where: 
𝑆𝑆𝑐𝑙𝑢𝑠𝑡𝑒𝑟 𝑅𝐶𝑇 = total sample size in a cluster RCT; 
𝑆𝑆𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑅𝐶𝑇 = total sample size in a standard RCT; 
DE = design effect, from (1). 
 
 
The number of participants required per group in a standard RCT can be readily calculated using 







   3) 
Where:  
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Z = the x’th percentage point of the standard normal distribution; 
 = clinically important difference between groups for the primary outcome measure; 
 = variance of primary outcome measure; 
 = significance level; 
 = power; 
𝑛𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙 𝑅𝐶𝑇 = sample size per group. 
 
 
While the approach described above is simple to implement, it assumes clusters with similar size. 
Recruitment for clinical trials is usually a challenge, and so most cluster trials tend to end up with 
unequal cluster sizes.7 This reduces the statistical power of the trial.8 Therefore, it is 
recommended that researchers adopt Equation (2) for estimating, a priori, the sample size of a 
cRCT with unequal cluster sizes, so that the trial will not be underpowered. Guidance on how to 
estimate the sample size requirement in a cRCT with unequal cluster sizes is provided below – 
but first, some considerations with regard to the number and size of clusters, and variability of 
the outcome between clusters. 
 
Number of clusters 
When estimating the sample size, researchers need to determine the number of clusters and the 
number of participants per cluster.20 Trials should avoid having too few clusters. Using a small 
number of clusters increases the required sample size (Table 1), because of variance inflation. 
The greater the number of clusters, the closer to a normal distribution data will be.18 Adding an 
extra cluster is an effective way to increase the power of a trial.6 However, adding an extra cluster 
to a trial will likely increase costs and logistical challenges, as it will involve recruiting a relatively 
large number of participants in order to match the size of the other clusters in the trial.3  
 
There are cases where the number of clusters is fixed due to geographical or logistic issues.3,9 In 
these cases, assuming that the size of clusters is equal, the number of clusters (defined a priori) 
will be appropriate as long as it is larger than the product of the number of required participants 
and the estimated ICC.9 
 
Ribeiro DC, Milosavljevic S, Abbott JH. Sample Size Estimation for Cluster Randomized Controlled Trials. 





Size of clusters 
The size of each cluster impacts on the statistical power of a trial, as it impacts on the variability 
of the outcome measure.20 The fewer participants per cluster, the smaller the required sample 
size (Table 1, Figure 1), however a greater number of clusters then becomes necessary. That 
occurs because the larger the cluster size, the larger the DE (Equation 1). 
 
In trials with unequal cluster sizes, the larger the size difference between clusters, the larger the 
sample required to achieve the same statistical power for a certain alpha (Figure 1). That happens 
because the outcome measure estimates from smaller clusters will be less precise than those from 
larger clusters, decreasing the statistical power.13 Therefore, cRCTs with unequal cluster sizes 
need to account for that loss on statistical power when estimating the sample size. 
 
Intracluster correlation coefficient 
The ICC is an estimate of how much variability is present among clustered data, and equals to the 
between-cluster variability divided by the sum of within- and between-cluster variability 
(Equation 4).10 The smaller the ICC, the more precise the outcome measure sampling, and the 
smaller the required sample size (Table 1).3  
 
Equation 4 





2      (4) 
Where: 
 = intracluster correlation coefficient; 
𝜎𝑏𝑒𝑡𝑤𝑒𝑒𝑛
2  = between-cluster variance for the outcome measure; 
𝜎𝑤𝑖𝑡ℎ𝑖𝑛
2  = within-cluster variance for the outcome measure. 
 
Outcome measurements are likely to be more similar within a cluster than between clusters,18 
impacting on the independence of measurements and causing variance inflation.6,18 Therefore, it 
is necessary to adjust the sample size to compensate for the loss in statistical power. 
 
A strategy to reduce the ICC consists of including baseline measurements as covariates when 
determining the outcome measure for each cluster.3,18 This results in reduced variance, as the 
change in scores between baseline and follow-up are generally less variable than are follow-up 
scores alone. 
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Ideally, researchers should conduct a pilot or feasibility trial16 prior to conducting the full cluster 
trial.1 Conducting a pilot or feasibility trial allows estimating the variability of the outcome 
measure and, most importantly in the case where cRCT is planned, it allows estimating the 
variability of the ICC.3     
 
Sample size estimation for cluster RCT with unequal cluster sizes 
The majority of trials tend to have unequal cluster sizes. Hence, researchers should consider 
cluster size variability when estimating the sample size.8,18 The challenge is to know the 
variability of the cluster size prior to starting data collection.18 Equation (5) can be used for 
estimating the design effect for unequal cluster sizes.8 This approach is considered conservative 
when planning individual-level analysis.8 
 
Equation 5 
𝐷𝐸𝑢𝑛𝑒𝑞𝑢𝑎𝑙 = 1 + [(1 + 𝑐𝑣
2) × ?̅? − 1]𝜌    (5)  
Where: 
cv = coefficient of variation of cluster size; 
?̅? = mean cluster size; 
𝜌 = intracluster correlation coefficient. 
 
When the coefficient of variation (cv) of cluster size is unknown, it can be estimated by entering 
the likely minimum and maximum cluster size. First, the standard deviation is estimated by 
Equation (6), and then the cv is estimated by Equation (7): 
 




       (6) 
 
𝑐𝑣 =  
𝑠𝑑
?̅?
      (7) 
Where:  
sd = standard deviation of cluster size; 
CSRange = cluster size range; 
cv = coefficient of variation of cluster size. 
 
The sample size for the cluster RCT is then determined (Equation 8)8,15: 
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𝑆𝑆𝑐𝑙𝑢𝑠𝑡𝑒𝑟 𝑅𝐶𝑇 = 𝑆𝑆𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑅𝐶𝑇 × 𝐷𝐸𝑢𝑛𝑒𝑞𝑢𝑎𝑙     (8) 
 
Where: 
𝑆𝑆𝑐𝑙𝑢𝑠𝑡𝑒𝑟 𝑅𝐶𝑇 = total sample size for cluster RCT; 
𝑆𝑆𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑅𝐶𝑇= total sample size for standard RCT; 
𝐷𝐸𝑢𝑛𝑒𝑞𝑢𝑎𝑙= design effect for unequal cluster size. 
 
Planned statistical analysis  
The statistical analysis of cRCTs may be undertaken by conducting cluster- or individual-level 
analysis.8,12 When conducting cluster-level analysis, outcomes are calculated for each cluster.8 In 
this case, the average of individual measurements is calculated within each cluster, and a linear 
regression model may be used.20 If clusters have the same size and there are no covariates, the 
approach is the same as conducting individual-level analysis.14,20 Cluster-level analysis reduces 
the data, and uses as input in the statistical analysis only one observation per cluster.8,18 While 
simple,18 this approach is not appropriate in cases where clusters do not have the same size18, 
which occurs in the majority of cases.7 In trials with variable cluster size, individual-level analysis 
should be planned18, this is considered more efficient than cluster-level analysis weighted by 
cluster size.12 This is commonly undertaken using linear mixed effects model that include cluster 
as random effects, or alternatively a generalised estimating equation (where the within-cluster 
correlation is modelled).18 
 
Outcome measures 
The formula used to estimate the sample size of a cRCT depends on the type of outcome measure 
(i.e. continuous, binary, count, ordinal, time-to-event, and rate). Musculoskeletal clinical 
researchers commonly use continuous outcome measures (e.g. VAS, disability scores). Thus, we 
are focusing on continuous outcome measures only. For more information on this topic, the 
reader is referred to the literature.3,18  
 
Allocation ratio 
Equal allocation ratio is the most efficient option requiring the smallest sample size. An unequal 
allocation ratio may be considered where issues limit the number of participants that can be 
recruited to a particular arm of the trial, such as cost of an intervention, limited number of 
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participants available, or difficulty recruiting people into a trial where there is a 50% chance of 
being allocated to an ‘unattractive’ group (e.g. no treatment).3,18 In such cases, consult a 
biostatistician for assistance with sample size calculations. 
 
Attrition 
In a standard RCT, participants may withdraw from the trial. In a cRCT, individual participants 
within a cluster or the whole cluster (less common) may withdraw. Attrition problems are likely 
to be higher in cRCTs where there can be lack of researcher contact with individual participants.3 
Researchers may include a drop-out rate for individuals or clusters into the sample size 
estimation to account for this withdrawal effect (e.g. to account for an estimated 20% dropout, it 
is necessary to add 25% more participants or two or more additional clusters into the trial, 
respectively).18 
 
Baseline measurements and other covariates  
Adding baseline measurements and other covariates in the analysis increases the statistical 
power. This is particularly useful to minimize the impact of smaller than planned sample size or 
higher than anticipated drop-out. Adding covariates reduces the between-cluster variability3, 
however adding covariates have no direct effect on a priori sample size calculations.   
 
Measurements may be taken at individual or cluster level. These measurements may include 
demographic characteristics (e.g. age, body mass index), and baseline measurements of the 
primary outcome measure.18 It is important that the covariate is associated with the primary 
outcome measure. For example, quadriceps muscle strength has been used in a trial on the 
management of knee osteoarthritis;2 and duration of symptoms in a trial on the management 
shoulder disorders.21 Measuring covariates may increase the cost of the trial; on the other hand, 
it will lead to a smaller sample size. If it is simple and inexpensive to gather additional 
information, then researchers should seriously consider this option. However, only useful 
additional data should be collected to minimize participant burden. It is possible to estimate and 
compare the costs of adding covariate measurements or increasing the sample size18. More details 
on the planning and sample size estimation of cRCTs (with different designs and outcome 
measures) can also be found in the literature.3,18 
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Cluster clinical trials have design strengths, but also carry challenges that need to be considered 
at the design stage by clinical researchers. We have discussed factors influencing the design and 
sample size estimation of cRCTs, and presented two approaches to estimate the sample size: one 
ideal for trials with balanced and another for trials with unequal cluster sizes.  
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